| S4902 |
QNZ (EVP4593) |
QNZ (EVP4593) shows potent inhibitory activity toward both NF-κB activation and TNF-α production with IC50 of 11 nM and 7 nM, respectively. |
Selective |
TNF-α, IC50: 7 nM |
| S1029 |
Lenalidomide (CC-5013) |
Lenalidomide (CC-5013) is a TNF-α secretion inhibitor with IC50 of 13 nM. |
Selective |
TNF-α, IC50: 13 nM |
| S1567 |
Pomalidomide |
Pomalidomide inhibits LPS-induced TNF-α release with IC50 of 13 nM. |
Selective |
TNF-α, IC50: 13 nM |
| S8037 |
Necrostatin-1 |
Necrostatin-1 is a specific RIP1 inhibitor and inhibits TNF-α-induced necroptosis with EC50 of 490 nM. |
Selective |
RIP1, EC50: 490 nM |
| S1193 |
Thalidomide |
Thalidomide was introduced as a sedative drug, immunomodulatory agent and also is investigated for treating symptoms of many cancers. Thalidomide inhibits an E3 ubiquitin ligase, which is a CRBN-DDB1-Cul4A complex. |
Selective |
|